Columbus, OH · Founded 2014 · Privately Held (backing)
Developer of a therapeutic platform designed to treat infectious and inflammatory eye diseases through activation of innate cellular defense and repair pathways. Invirsa is based in Columbus, OH and was founded in 2014. Its last reported valuation was $38 million in Nov 2023. It has raised $14.3 million across 3 recorded rounds; the latest was a $2.9 million seed round in Jul 2025.
Last reported valuation
$38.0M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Jul 2025
Team — not yet on record
No current team members for Invirsa are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Invirsa with a free account
·Watch Invirsa: the Monday email on marks, rounds and moves
